Products classification
ABOUT US
Email:
sales@ruixibiotech.com
Tel.:
02988811435
Home > products > apis> gpcr-g-protein
Catalog name Description price
R-R-4224 Proglumide sodium CAS No.99247-33-3 Proglumide sodium/CAS No.99247-33-3 is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide sodium has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide sodium also has antiepileptic and antioxidant activities. price>
R-R-4225 Proglumide CAS No.6620-60-6 Proglumide/CAS No.6620-60-6 is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide selective blocks CCK’s effects in the central nervous system (CNS). Proglumide has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide also has antiepileptic and antioxidant activities. price>
R-R-4226 SR 146131 CAS No.221671-61-0 SR 146131/CAS No.221671-61-0 is a potent, orally available, and selective nonpeptide (cholecystokinin 1) receptor agonist. price>
R-R-4227 A71623 CAS No.130408-77-4 A71623/CAS No.130408-77-4, a CCK-4-based peptide, is a potent and highly selective CCK-A full agonist. The IC50s for A-71623 are 3.7 nM in guinea pig pancreas (CCK-A) and 4500 nM in cerebral cortex (CCK-B) in radioligand binding assays, respectively. price>
R-C-2528 Losartan potassium CAS：124750-99-8 Losartan potassium(DuP-753 potassium)is an angiotensin II receptor type 1 (AT1)antagonist,competing with the binding of angiotensin II to AT1 with an IC50 of 20nM. price>
R-R-4228 Lorglumide sodium salt CAS No.1021868-76-7 Lorglumide sodium salt (CR-1409 sodium salt)/CAS No.1021868-76-7 is a potent cholecystokinin (CCK) receptor antagonist. price>
R-R-4229 Lintitript CAS No.136381-85-6 Lintitript (SR 27897)/CAS No.136381-85-6 is a highly potent, selective, orally active, competitive and non-peptide cholecystokinin (CCK1) receptor antagonist with an EC50 of 6 nM and a Ki of 0.2 nM. Lintitript displays > 33-fold selectivity more selective for CCK1 than CCK2 receptors (EC50 value of 200 nM). Lintitript increases plasma concentration of leptin and food intake as well as plasma concentration of insulin. price>
R-R-4230 Dexloxiglumide CAS No.119817-90-2 Dexloxiglumide/CAS No.119817-90-2 is a selective cholecystokinin type A (CCKA) receptor antagonist. Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8). price>
R-R-4231 CCK-B Receptor Antagonist 2 CAS No.155412-88-7 CCK-B Receptor Antagonist 2/CAS No.155412-88-7, compound 15b, is a potent and orally active Gastrin/CCK-B antagonist with an IC50 value of 0.43 nM. CCK-B Receptor Antagonist 2 also inhibits gastrin/CCK-A activity with an IC50 of 1.82 μM. price>
R-R-4232 L-365260 hemihydrate L-365260 hemihydrate is an orally active and selective antagonist of non-peptide gastrin and brain cholecystokinin receptor (CCK-B), with Kis of 1.9 nM and 2.0 nM, respectively. L-365260 hemihydrate interacts in a stereoselective and competitive manner with guinea pig stomach gastrin and brain CCK receptors. price>